Prescriber Checkup

Prescriber Checkup

The Doctors and Drugs in Medicare Part D

JOSE FELICIANO PEREZ M.D.

At A Glance: This Prescriber in 2016

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,936Medicare Part D Prescriptions Filled, Including Refills
$579K Total Retail Price of All Prescriptions
559 Patients Receiving at Least One Drug in Part D
78% Patients 65 Years and Older

3% Subsidized Claims for Low-Income Patients


This Provider's History

A comparison of this provider’s prescribing in Part D since 2014. All years may not be shown if there is insufficient data.

Cost of Claims

$462K

2014

$507K

2015

$579K

2016

Number of Claims

14,833

2014

15,947

2015

16,936

2016

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state. The list below includes only those drugs for which this provider wrote 50 or more prescriptions.

Click to Filter by Category

Clear Filter


O

An opioid drug. More » Prescription opioids (painkillers) can help alleviate certain kinds of pain in the short term but carry serious health risks.

A

An antibiotic drug. More » Used to treat bacterial infections but are often prescribed incorrectly to treat viral infections, such as chest colds or the flu.

P

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

10

This provider is among the top 10 prescribers of this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Receiving this Drug Category
SIMVASTATIN 1,144

prescriptions, 7% of all prescriptions

939

prescriptions.

195

patients, 35% of all patients

OMEPRAZOLE 880

prescriptions, 5% of all prescriptions

670

prescriptions.

159

patients, 28% of all patients

RANITIDINE HCL 859

prescriptions, 5% of all prescriptions

649

prescriptions.

163

patients, 29% of all patients

ENALAPRIL MALEATE 618

prescriptions, 4% of all prescriptions

481

prescriptions.

90

patients, 16% of all patients

LEVOTHYROXINE SODIUM 563

prescriptions, 3% of all prescriptions

479

prescriptions.

91

patients, 16% of all patients

METFORMIN HCL 530

prescriptions, 3% of all prescriptions

432

prescriptions.

98

patients, 18% of all patients

GABAPENTIN 483

prescriptions, 3% of all prescriptions

363

prescriptions.

99

patients, 18% of all patients

LOSARTAN POTASSIUM 439

prescriptions, 3% of all prescriptions

365

prescriptions.

75

patients, 13% of all patients

SYNTHROID 380

prescriptions, 2% of all prescriptions

295

prescriptions.

60

patients, 11% of all patients

FUROSEMIDE 360

prescriptions, 2% of all prescriptions

317

prescriptions.

61

patients, 11% of all patients

AMLODIPINE BESYLATE 333

prescriptions, 2% of all prescriptions

303

prescriptions.

58

patients, 10% of all patients

GLIMEPIRIDE 328

prescriptions, 2% of all prescriptions

294

prescriptions.

49

patients, 9% of all patients

METOPROLOL SUCCINATE 310

prescriptions, 2% of all prescriptions

247

prescriptions.

57

patients, 10% of all patients

ATENOLOL 300

prescriptions, 2% of all prescriptions

254

prescriptions.

43

patients, 8% of all patients

FAMOTIDINE* 300

prescriptions, 2% of all prescriptions

228

prescriptions.

75

patients, 13% of all patients

CLOPIDOGREL 275

prescriptions, 2% of all prescriptions

216

prescriptions.

39

patients, 7% of all patients

ATORVASTATIN CALCIUM 272

prescriptions, 2% of all prescriptions

206

prescriptions.

53

patients, 9% of all patients

CLONAZEPAM 255

prescriptions, 2% of all prescriptions

217

prescriptions.

59

patients, 11% of all patients

ISOSORBIDE MONONITRATE ER 247

prescriptions, 1% of all prescriptions

209

prescriptions.

39

patients, 7% of all patients

LOSARTAN-HYDROCHLOROTHIAZIDE 245

prescriptions, 1% of all prescriptions

213

prescriptions.

44

patients, 8% of all patients

DOXAZOSIN MESYLATE 237

prescriptions, 1% of all prescriptions

220

prescriptions.

35

patients, 6% of all patients

FENOFIBRATE* 235

prescriptions, 1% of all prescriptions

140

prescriptions.

44

patients, 8% of all patients

GLIPIZIDE 227

prescriptions, 1% of all prescriptions

189

prescriptions.

31

patients, 6% of all patients

LISINOPRIL 221

prescriptions, 1% of all prescriptions

188

prescriptions.

31

patients, 6% of all patients

CARVEDILOL 215

prescriptions, 1% of all prescriptions

175

prescriptions.

43

patients, 8% of all patients

METOPROLOL TARTRATE 191

prescriptions, 1% of all prescriptions

163

prescriptions.

42

patients, 8% of all patients

METFORMIN HCL ER 184

prescriptions, 1% of all prescriptions

159

prescriptions.

42

patients, 8% of all patients

HUMULIN 70-30 178

prescriptions, 1% of all prescriptions

122

prescriptions.

22

patients, 4% of all patients

HYDROCHLOROTHIAZIDE 144

prescriptions, 1% of all prescriptions

139

prescriptions.

24

patients, 4% of all patients

PANTOPRAZOLE SODIUM 143

prescriptions, 1% of all prescriptions

103

prescriptions.

31

patients, 6% of all patients

AZITHROMYCIN 140

prescriptions, 1% of all prescriptions

99

prescriptions.

105

patients, 19% of all patients

A
OXYCODONE-ACETAMINOPHEN 135

prescriptions, 1% of all prescriptions

29

prescriptions.

24

patients, 4% of all patients

O
TRAMADOL HCL 130

prescriptions, 1% of all prescriptions

48

prescriptions.

35

patients, 6% of all patients

O
NABUMETONE 130

prescriptions, 1% of all prescriptions

91

prescriptions.

34

patients, 6% of all patients

MONTELUKAST SODIUM 129

prescriptions, 1% of all prescriptions

63

prescriptions.

43

patients, 8% of all patients

TAMSULOSIN HCL 120

prescriptions, 1% of all prescriptions

115

prescriptions.

25

patients, 4% of all patients

ALPRAZOLAM 117

prescriptions, 1% of all prescriptions

112

prescriptions.

21

patients, 4% of all patients

TRAMADOL HCL-ACETAMINOPHEN 108

prescriptions, 1% of all prescriptions

83

prescriptions.

37

patients, 7% of all patients

O
MELOXICAM 104

prescriptions, 1% of all prescriptions

67

prescriptions.

52

patients, 9% of all patients

CLOTRIMAZOLE-BETAMETHASONE 99

prescriptions, 1% of all prescriptions

94

prescriptions.

38

patients, 7% of all patients

WARFARIN SODIUM 97

prescriptions, 1% of all prescriptions

81

prescriptions.

15

patients, 3% of all patients

PRAVASTATIN SODIUM 97

prescriptions, 1% of all prescriptions

92

prescriptions.

14

patients, 3% of all patients

LANTUS 96

prescriptions, 1% of all prescriptions

76

prescriptions.

21

patients, 4% of all patients

LANSOPRAZOLE 95

prescriptions, 1% of all prescriptions

65

prescriptions.

17

patients, 3% of all patients

INSULIN SYRINGE* 81

prescriptions, 0% of all prescriptions

47

prescriptions.

15

patients, 3% of all patients

BETAMETHASONE DIPROPIONATE* 79

prescriptions, 0% of all prescriptions

55

prescriptions.

29

patients, 5% of all patients

JANUVIA 78

prescriptions, 0% of all prescriptions

73

prescriptions.

13

patients, 2% of all patients

IRBESARTAN 77

prescriptions, 0% of all prescriptions

72

prescriptions.

15

patients, 3% of all patients

DONEPEZIL HCL 74

prescriptions, 0% of all prescriptions

74

prescriptions.

17

patients, 3% of all patients

ZETIA 72

prescriptions, 0% of all prescriptions

52

prescriptions.

<11
VERAPAMIL ER 70

prescriptions, 0% of all prescriptions

52

prescriptions.

12

patients, 2% of all patients

HUMULIN N 62

prescriptions, 0% of all prescriptions

62

prescriptions.

<11
MECLIZINE HCL 62

prescriptions, 0% of all prescriptions

57

prescriptions.

21

patients, 4% of all patients

VALSARTAN 60

prescriptions, 0% of all prescriptions

43

prescriptions.

11

patients, 2% of all patients

IRBESARTAN-HYDROCHLOROTHIAZIDE 60

prescriptions, 0% of all prescriptions

55

prescriptions.

<11
ALENDRONATE SODIUM 59

prescriptions, 0% of all prescriptions

54

prescriptions.

<11
SPIRONOLACTONE 56

prescriptions, 0% of all prescriptions

51

prescriptions.

14

patients, 3% of all patients

KETOCONAZOLE 56

prescriptions, 0% of all prescriptions

35

prescriptions.

35

patients, 6% of all patients

SURE COMFORT* 55

prescriptions, 0% of all prescriptions

55

prescriptions.

<11
DIGOXIN 54

prescriptions, 0% of all prescriptions

43

prescriptions.

<11
TEMAZEPAM 52

prescriptions, 0% of all prescriptions

34

prescriptions.

<11
ALLOPURINOL 50

prescriptions, 0% of all prescriptions

15

prescriptions.

<11
DIGOX 50

prescriptions, 0% of all prescriptions

45

prescriptions.

<11
SERTRALINE HCL 50

prescriptions, 0% of all prescriptions

45

prescriptions.

13

patients, 2% of all patients

About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. The data for 2016 includes more than 1.5 billion prescriptions written by 1.1 million doctors, nurses and other providers. This database lists over 460,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. More than three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to [email protected] and we will update your information. If you have other questions about this data, send a note to [email protected].

Caveats
  • No comparisons are shown if there are fewer than 20 prescribers in the state share this specialty.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 27, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.
  • In rare circumstances, providers' prescription tallies may be inflated. Sometimes providers are credited with prescriptions written by colleagues (this happens in long-term care facilities) or are victims of fraud involving theft of their provider number.